These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30830433)

  • 1. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.
    Piersigilli F; Lam TT; Vernocchi P; Quagliariello A; Putignani L; Aghai ZH; Bhandari V
    Metabolomics; 2019 Feb; 15(2):20. PubMed ID: 30830433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease.
    Fanos V; Pintus MC; Lussu M; Atzori L; Noto A; Stronati M; Guimaraes H; Marcialis MA; Rocha G; Moretti C; Papoff P; Lacerenza S; Puddu S; Giuffrè M; Serraino F; Mussap M; Corsello G
    J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():39-45. PubMed ID: 25284176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.
    Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia.
    Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O
    Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia.
    Hendricks-Muñoz KD; Xu J; Voynow JA
    Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia.
    Baraldi E; Giordano G; Stocchero M; Moschino L; Zaramella P; Tran MR; Carraro S; Romero R; Gervasi MT
    PLoS One; 2016; 11(10):e0164211. PubMed ID: 27755564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary
    Pintus MC; Lussu M; Dessì A; Pintus R; Noto A; Masile V; Marcialis MA; Puddu M; Fanos V; Atzori L
    Oxid Med Cell Longev; 2018; 2018():7620671. PubMed ID: 30050661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia.
    van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW
    PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome.
    El Shemi MS; Tawfik S; Khafagy SM; Hamza MT; Youssef AM
    J Neonatal Perinatal Med; 2017; 10(1):79-83. PubMed ID: 28304322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates.
    Schneibel KR; Fitzpatrick AM; Ping XD; Brown LA; Gauthier TW
    J Perinatol; 2013 May; 33(5):383-7. PubMed ID: 23047424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions.
    Ahmed S; Odumade OA; van Zalm P; Fatou B; Hansen R; Martin CR; Angelidou A; Steen H
    J Pediatr; 2024 Jul; 270():113774. PubMed ID: 37839510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
    Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
    Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia.
    Yen E; Weinberger BI; Laumbach RJ; Ohman-Strickland PA; Vetrano AM; Gow AM; Ramagopal M
    J Neonatal Perinatal Med; 2018; 11(4):399-407. PubMed ID: 30040745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia.
    Niu JO; Munshi UK; Siddiq MM; Parton LA
    J Pediatr; 1998 Jun; 132(6):965-70. PubMed ID: 9627587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns.
    Nobile S; Marchionni P; Gidiucci C; Correani A; Palazzi ML; Spagnoli C; Rondina C; ; Carnielli VP
    Pediatr Pulmonol; 2019 May; 54(5):637-643. PubMed ID: 30688034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.
    Alvarez-Fuente M; Moreno L; Lopez-Ortego P; Arruza L; Avila-Alvarez A; Muro M; Gutierrez E; Zozaya C; Sanchez-Helguera G; Elorza D; Martinez-Ramas A; Villar G; Labrandero C; Martinez L; Casado T; Cuadrado I; Del Cerro MJ
    PLoS One; 2019; 14(3):e0213210. PubMed ID: 30840669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
    Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
    Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
    Woynarowska M; Rutkowska M; Szamotulska K
    Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Munshi UK; Niu JO; Siddiq MM; Parton LA
    Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.